TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) (the 'Company' or 'TAAT') is pleased to announce that the Menthol variety of TAAT, its flagship product, was the first to sell out during the initial weeks of availability of TAAT products at retail in Ohio.

Tobacco retailers who sold out of TAAT Menthol have placed reorders through their respective tobacco distributors who carry TAAT. The Company continues to focus its efforts on commercializing all three varieties of TAAT in a balanced manner to legal-aged smokers in the state of Ohio, while continuously analyzing sales data for TAAT Original, Smooth, and Menthol to develop strategies that are specific to each product variety based on actual market performance.

In a press release dated July 3, 2020, the Company outlined its provisional strategy for gaining market share in the menthol subset of the USD $814 billion global tobacco industry, a segment which was valued at approximately USD $80 billion in 2018 by Grand View Research1 . Menthol cigarettes, which were invented in Ohio in 19242 , gained popularity due to the unique 'cooling' sensation from added menthol (C10H20O). The first major brand of menthol cigarettes in the United States, known as Kools, advertised 'throat comfort' as a defining attribute in comparison to traditional tobacco cigarettes. Major tobacco companies began offering standalone brands of menthol cigarettes beginning in the 1950s including R.J. Reynolds (Salem), Lorillard (Newport, Spring), and Philip Morris (Alpine) 3 . Menthol cigarettes remain immensely popular in the United States, with Newport menthol cigarettes holding a market share of approximately 14%, second only to Marlboro4.

The popularity of TAAT Menthol could play a key role in potential expansion initiatives by the Company in the northeastern United States due to a high proportion of menthol combustible tobacco sales in specific states. Based on data from 2011 through 2016 sourced by Nielsen, the three states with the highest proportion of menthol cigarettes in combustible tobacco sales were Pennsylvania (45%), Maryland (44%), and Delaware (43.3%)5 . In the same data, Ohio's proportion of menthol cigarettes in combustible tobacco sales was just 31.3%. Internationally, menthol cigarettes hold substantial market share in several Asian markets such as the Philippines (estimated by Philip Morris to be 49.4% in 20106 ), one of the countries in which TAAT recently filed trademark applications. The Company's distribution partners have managed to fulfill reorders of TAAT Menthol as part of standard routing procedures. In an effort to create a competitive edge in a given market, the Company is diligently establishing and maintaining a robust distribution network in order to ensure a constant availability of TAAT at all points of sale. Furthermore, a multi-pallet shipment of TAAT Original, Smooth, and Menthol is destined to arrive in Ohio later this quarter as the Company continues to build out the presence of TAAT in its initial market.

About TAAT Lifestyle & Wellness Ltd.

The Company has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in 'Original', 'Smooth', and 'Menthol' varieties. TAAT's base material is Beyond Tobacco, a proprietary blend which undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with 'Big Tobacco' pedigree, TAAT is launching in the United States in Q4 2020 as the Company seeks to position itself in the $814 billion1 global tobacco industry.

Forward-Looking Statements

This news release contains 'forward-looking information' within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as 'plans', 'expects' or 'does not expect', 'is expected', 'estimates', 'intends', 'anticipates' or 'does not anticipate', or 'believes', or variations of such words and phrases or state that certain actions, events or results 'may', 'could', 'would', 'might' or 'will' be taken, occur, or be achieved. Forward-looking information in this news release includes statements regarding the potential launch of Beyond Tobacco, in addition to the following: Potential future performance of TAAT Menthol in Ohio or other markets in which the product may be made available for purchase by legal-aged smokers. The forward-looking information reflects management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the tobacco markets and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company's management to predict all risk factors, nor can the Company assess the impact of all factors on Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forwardlooking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company's products will vary from person to person. No claims or guarantees can be made as to the effects of the Company's products on an individual's health and well-being. The Company's products are not intended to diagnose, treat, cure, or prevent any disease. This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.

Contact:

Tel: 1-833-822-8872

(C) 2021 Electronic News Publishing, source ENP Newswire